DAVITA INC. Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31)
DAVITA INC. (DVA) reported Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) of $9.37 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Expense Statement › Income Tax
us-gaap:TaxBenefitFromStockOptionsExercised1 · last filed 2013-05-09
- DAVITA INC. tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $9.37M, a 13.98% decline year-over-year.
- DAVITA INC. tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $28.71M, a 825.30% increase year-over-year.
- DAVITA INC. tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $32.67M, a 2354.47% increase year-over-year.
- DAVITA INC. tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $16.69M.
- DAVITA INC. tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2012 was $88.96M, a 132.90% increase from fiscal 2011.
- DAVITA INC. tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2011 was $38.20M, a 43.04% increase from fiscal 2010.
- DAVITA INC. tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2010 was $26.71M.
| Period end | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 3 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 6 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 9 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $9.37M 10-Q · filed 2013-05-09 | $38.08M derived: sum of 2 quarters · filed 2013-05-09 | $70.75M derived: sum of 3 quarters · filed 2013-05-09 | $87.44M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-12-31 | $28.71M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $61.38M derived: sum of 2 quarters · filed 2013-03-01 | $78.07M derived: sum of 3 quarters · filed 2013-03-01 | $88.96M 10-K · filed 2013-03-01 |
| 2012-09-30 | $32.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $49.36M derived: sum of 2 quarters · filed 2012-10-31 | $60.25M 10-Q · filed 2012-10-31 | $63.35M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-06-30 | $16.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $27.58M 10-Q · filed 2012-08-03 | $30.69M derived: sum of 3 quarters · filed 2013-05-09 | $32.02M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-03-31 | $10.89M 10-Q · filed 2013-05-09 | $13.99M derived: sum of 2 quarters · filed 2013-05-09 | $15.32M derived: sum of 3 quarters · filed 2013-05-09 | |
| 2011-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $4.43M derived: sum of 2 quarters · filed 2013-03-01 | $38.20M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $35.10M 10-Q · filed 2012-10-31 | ||
| 2011-06-30 | $33.77M 10-Q · filed 2012-08-03 | |||
| 2010-12-31 | $26.71M 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |